Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Title Valve Performance of the SAPIEN 3 Ultra RESILIA Valve: A Prospective Registry With Central Echocardiography Analysis.

NCT06420830 is registered in ClinicalTrials.gov with Institut universitaire de cardiologie et de pneumologie de Québec, University Laval as lead sponsor.

NCT NCT06420830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06420830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Title Valve Performance of the SAPIEN 3 Ultra RESILIA Valve: A Prospective Registry With Central Echocardiography Analysis.
Lead sponsor
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Phase
Observational
Overall status
Recruiting
Start date
May 16, 2024
Completion date
September 1, 2034
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve stenosis, transcatheter aortic valve replacement